Medical Tourism Market in Asia: Focus on Thailand, Malaysia, Singapore & India
| Publication Date | April 2008 |
|---|---|
| Publisher | Koncept Analytics |
| Product Type | Report |
| Pages | 28 |
| ISBN Number | not applicable |
| Product Code | KOA04270 |
Summary
Medical or health tourism is among the fastest growing industries in the world. The major forces driving growth of this emerging industry include the rising cost of healthcare and limiting scope of insurance coverage in developed countries, increasing waiting time for treatments, and low cost of treatments elsewhere.
Medical tourism market is characterized by tough competition in the Asian countries. Health system in Singapore is ranked as the best in Asia and amongst the best in the world. The country is well known for quality medicine and state-of-the art medical care. Growth in the medical tourism sector in Thailand has been largely led by the private sector. The number of foreign patients in Malaysia is projected to grow at a rate of about 25-30 percent until 2010. India, on the other hand, offers medical treatment at the lowest cost along with providing alternate therapies like yoga, ayurveda, aromatherapy, and acupuncture.
Thailand is the only country which is faced with tough competition from both ends, low-cost treatments from India and Malaysia as well as high-end medical services from Singapore. In the meantime, price difference between Singapore and Thailand is also reducing at a significant rate. All the leading hospitals in Asian countries are getting themselves accredited by international associations.
This report gives an overview of the medical tourism industry with its growth drivers and trends. It discusses the main medical tourist destinations of Asia and their respective competitive advantages. The major healthcare organizations in Asia are also discussed in the later part of the report.
Content
- 1. Medical Tourism: An Overview
- Introduction
- Services Offered
- 2. Market Overview
- 2.1 Worldwide
- Market Value
- 2.2 Asia
- Major Healthcare Groups
- Comparative Cost of Treatment
- 2.3 Thailand
- Inflow of Foreign Patients
- Revenue from Foreign Patients
- Medical Tourists by Country
- 2.3.2 Malaysia
- Tourist Arrivals Growth
- Health Expenditure
- 2.3.3 Singapore
- Inflow of Foreign Patients
- 2.3.4 India
- Breakdown of Foreign Tourists by Purpose of Visit
- Tourists Arrivals
- Major Players in Medical Tourism Industry
- 2.1 Worldwide
- 3. Market Drivers
- 3.1 Outsourcing of Patients by Insurers
- 3.2 Quality of Treatment
- 4. Key Issues
- 4.1 Rising Value of Indian Currency
- 4.2 Upgradation of Infrastructure
- 4.3 Co-ordination Between Healthcare and Tourism Sectors
- 4.4 Standardization in Pricing
- 4.5 Impact on Domestic Healthcare Services
- 4.6 Other Risks in Medical Tourism
- 5. Company Profiles
- 5.1 Bumrungrad Hospital
- Overview
- Significant Developments
- 5.2 Bangkok Hospital Medical Center
- Overview
- 5.3 Apollo Hospitals
- Overview
- Significant Developments
- 5.4 Wokhardt Hospital
- Overview
- 5.5 Parkway Hospitals
- Overview
- Medical Tourism - Service Network
- Worldwide Medical Tourism Market (2004-12E)
- Thailand - Inflow of Foreign Patients (2000-2010E)
- Thailand - Revenue from Foreign Patients (2000-2010E)
- Thailand - Medical Tourists by Country of Origin
- Malaysia - Tourist Arrivals Growth (2002-07)
- Malaysia - Health Expenditure (Public versus Private)
- Singapore - International Patient Inflow (2001-06)
- India - SWOT Analysis
- Major Healthcare Groups in Asia
- Comparative Cost of Treatment in Asian Countries
- Ratio of Medical Care Resources to Population in Asian Countries
- India - Major Players in Medical Tourism Industry
- India - Breakdown of Foreign Tourists by Purpose of Visit
- India - Breakdown of NRIs by Purpose of Visit
- India - Tourists Arrivals (2001-07)
- Exchange Rate for INR against USD (2007)
- JCI Accredited Hospitals in Major Asian Countries
- 5.1 Bumrungrad Hospital
About this Product
Delivery Details
PDF:Delivered by email within 24 to 48 hours of placing the order (Mon-Fri)
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















